Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT study
| Image |  |
|---|---|
| Description | scientific article published on 22 February 2020 |
| Author/s |
author: Eric Lawitz Leen Vijgen Veerle Van Eygen |
| Publication date | February 22, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |